The dynamic field of psychotropic medication has seen groundbreaking results with the introduction of dissociative therapies. This episode hopes to shed light on the use of ketamine for mental health and chronic pain relief and put an emphasis on how CRNAs are uniquely positioned to benefit from its application. Dr. Nicholas Kalynych and Brian Hogan of Sunbelt Wellness Institute will join the show to help us do that. Read more about the show here: https://beyondthemaskpodcast.com/ep-101-how-ketamine-infusion-therapy-is-treating-mental-health/2700/ Get the CE certificate here: https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf What we discuss on this episode: 2:22 – What we’re talking about today 3:04 – Background on our guests 6:32 – What’s important about this topic right now? 7:21 – This history and uses of ketamine 10:28 – Microdosing 12:52 – Stigma of mental health 14:25 – Ketamine with other anti-depressants 16:19 – What’s the stigma attached to ketamine 18:09 – How their business got involved with this treatment. 21:23 – Insurance not covering this right now 22:36 – How can CRNAs get more involved with this? 24:30 – Why CRNAs are uniquely qualified 27:39 – How did these uses for ketamine come about? 30:24 – The role of a psychiatrist 34:30 – How they help people get started with this. 38:53 – How is COVID impacting supply? 45:03 – Final message on the topic

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related